News Ibnsina Pharma

Equities

ISPH

EGS512O1C012

End-of-day quote Egyptian Exchange Other stock markets 23:00:00 01/05/2024 BST			5-day change	1st Jan Change
2.46 ^EGP	+1.23%		-4.65%	-21.66%

03-03	Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-05	Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	03-03	CI
Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index	02-04	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/08/23	CI
Ibnsina Pharma(CASE:ISPH) dropped from EGX 30 Index	02/08/23	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023	23/05/23	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022	01/03/23	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22	CI
Ibnsina Pharma(CASE:ISPH) dropped from S&P Global BMI Index	19/09/22	CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	14/08/22	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022	22/05/22	CI
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.	21/05/22	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021	23/03/22	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	14/11/21	CI
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	16/08/21	CI
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021	01/06/21	CI
Ibnsina Pharma Announces Board Changes	04/04/21	CI
Ibnsina Pharma Appoints Mohamed Mohsen Mohamed Mahgoub as CEO	04/04/21	CI
Ibnsina Pharma Reports Earnings Results for the Full Year 2020	04/04/21	CI
Ibn Sina Pharma (S.A.E) Announces Audited Standalone Earnings Results for the Full Year Ended December 31, 2020	28/02/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ibnsina Pharma

Equities

ISPH

EGS512O1C012

Summary

Filters